The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more.  The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial.

In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q² Solutions company, describes that ecosystem and the lifecycle of patient samples. 

She describes:

• The varying approaches of small vs. large laboratories
• Risks of insufficient tracking
• Tracking consent for future use
• Current practice and opportunities for improved tracking